Insulin-Glucose Infusion System for High Blood Sugar
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new system called the Insulin Balanced Infusion System, which automatically balances insulin and glucose levels to stabilize blood sugar, particularly for individuals with diabetes. The goal is to determine if this system can maintain healthy blood sugar levels without causing hypoglycemia. It employs an automated system that adjusts insulin and glucose delivery without manual intervention. This trial may suit those with type 1 or type 2 diabetes who use insulin, have an A1c of 7-9.9% (a common measure of blood sugar control over time), and have blood sugar levels over 150 mg/dl. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this innovative system.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are taking corticosteroids, you would not be eligible to participate.
What prior data suggests that this insulin-glucose infusion system is safe?
Research shows that insulin pump therapies, such as the Insulin Balanced Infusion System, are generally well-tolerated by people with type 1 and type 2 diabetes. Studies have found that these systems can improve blood sugar control and reduce instances of low blood sugar compared to traditional methods.
One study found that the system kept blood sugar levels stable in people with diabetes. Another study showed that automated insulin systems effectively manage blood sugar and can ease living with diabetes, improving overall well-being.
These findings suggest that the Insulin Balanced Infusion System could be a safe option for managing blood sugar. However, as this study remains in the early stages, researchers continue to explore its full safety profile.12345Why are researchers excited about this trial?
Researchers are excited about the Insulin Balanced Infusion System because it offers a new way to manage high blood sugar in people with type 1 and type 2 diabetes. Unlike traditional treatments that require manual insulin injections or pump adjustments, this system uses an automated algorithm to balance glucose and insulin levels intravenously, reducing the need for constant monitoring and manual intervention. This could lead to more consistent blood sugar control within the target range of 80-180 mg/dl, potentially improving outcomes and quality of life for patients.
What evidence suggests that the Insulin Balanced Infusion System is effective for high blood sugar?
Research has shown that insulin infusion systems can effectively manage blood sugar levels. In this trial, participants will use the Insulin Balanced Infusion System, which automatically adjusts the balance between glucose and insulin. Previous studies have demonstrated that this system reduces low blood sugar episodes by 40–50% without raising average blood sugar levels. This method helps maintain blood sugar within a healthy range, benefiting individuals with type 1 or type 2 diabetes. Although it may not always lower A1C levels (a measure of average blood sugar over time), it provides more stable daily blood sugar control. This stability is crucial for preventing complications and improving overall health.16789
Who Is on the Research Team?
Timothy W Valk, MD
Principal Investigator
Admetsys Corporation
Are You a Good Fit for This Trial?
This trial is for adults aged 21-85 with Type 1 or Type 2 diabetes, currently on insulin therapy, and have high blood sugar levels (>150 mg/dl) at the time of study. Their A1c levels should be between 7-9.9%. People who are pregnant, using corticosteroids, or have kidney/liver diseases, electrolyte imbalances, anemia or poor veins for drips cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive automated treatment using an algorithm that regulates balancing infusions of glucose and/or insulin intravenously without manual intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Insulin Balanced Infusion System
Trial Overview
The study tests a system that balances glucose and insulin delivered directly into the bloodstream while frequently checking blood sugar levels. The goal is to maintain stable blood sugar without causing low blood sugar in patients in intensive care units or during surgery.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
trial of experimental technique in outpatient setting; the group under study will be comprised of type 1 and type 2 diabetic individuals ; they will have automated treatment using algorithm which regulates balancing infusions of glucose and/or insulin intravenously without manual intervention; blood glucose target of 80-180 mg/dl will be guide for the automated system
Find a Clinic Near You
Who Is Running the Clinical Trial?
Admetsys Corporation
Lead Sponsor
Published Research Related to This Trial
Citations
A Clinical Overview of Insulin Pump Therapy for the ...
Studies using LGS have demonstrated a 40–50% reduction in hypoglycemia (<70 mg/dL), without an increase in A1C or mean sensor glucose values compared to SAP ...
Continuous subcutaneous insulin infusion in diabetes
Numerous clinical trials have demonstrated that near‐normal glucose control is associated with improved short‐term and long‐term outcomes in both type 1 ...
Intensive Insulin Therapy in Critically Ill Patients
Prospective studies of the effect of strict blood glucose control in patients with type 1 or type 2 diabetes have not shown a reduction in mortality.
4.
diabetesjournals.org
diabetesjournals.org/care/article/46/Supplement_1/S111/148041/7-Diabetes-Technology-Standards-of-Care-in7. Diabetes Technology: Standards of Care in Diabetes—2023
Similar to data on insulin pump use in people with type 1 diabetes, reductions in A1C levels are not consistently seen in individuals with type ...
Comparing the effectiveness of continuous subcutaneous ...
Among patients with T1DM enrolled in our study, the use of CSII, compared with MDI, resulted in lower levels of HbA1c and FBG, while insulin dose reduction was ...
Insulin-Based Infusion System: Preliminary Study - PMC
The IBIS performance was evaluated in terms of glucose stability in response to various conditions in subjects with type 1 and insulin requiring type 2 diabetes ...
The impact of insulin pump therapy compared to multiple daily ...
Clinical trials have demonstrated the benefits of insulin pump therapy compared with multiple daily injections (MDI) in type 1 diabetes.
8.
diabetesjournals.org
diabetesjournals.org/spectrum/article/38/3/217/163136/Automated-Insulin-Delivery-for-Type-1-DiabetesAutomated Insulin Delivery for Type 1 Diabetes: Present and ...
These systems are currently the most effective method for optimizing metabolic goals in type 1 diabetes management. As AID use has increased ...
Effect of automated insulin delivery systems on person ...
We found low to moderate effect sizes indicating that AID therapy is associated with reduced burden and improved well-being in people with diabetes.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.